Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (251-260 of 910) with videos related to

Pageof 91
Sort By:
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
The Canadian Journal of Cardiology|April 5, 2003
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromesFadi H Khadour, Yuling Fu, Wei-Ching Chang, et al.
European Heart Journal|April 26, 2003
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus studyLars Wallentin, Lott Bergstrand, Mikael Dellborg, et al.
American Heart Journal|April 9, 2011
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline riskRajendra H Mehta, Aijing Z Starr, Renato D Lopes, et al.
Journal of Interventional Cardiology|August 30, 2008
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussionMarc Cohen, James Hoekstra, Robert Giugliano, et al.
The Lancet. Neurology|March 21, 2014
Embolic strokes of undetermined source: the case for a new clinical constructRobert G Hart, Hans-Christoph Diener, Shelagh B Coutts, et al.
American Journal of Epidemiology|March 7, 2015
Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External ExpertsVéronique L Roger, Eric Boerwinkle, James D Crapo, et al.
Journal of the American Geriatrics Society|December 20, 2022
Lipid-lowering treatment among older patients with atherosclerotic cardiovascular diseaseMichael G Nanna, Adam J Nelson, Kevin Haynes, et al.
European Journal of Heart Failure|September 6, 2017
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortalityElke Platz, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 91

Showing results (251-260 of 910) with videos related to

Sort By:
Pageof 91
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
Frontiers in Genetics|October 3, 2022
Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic eventsSofia Attelind, Pär Hallberg, Mia Wadelius, et al.
The Canadian Journal of Cardiology|April 5, 2003
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromesFadi H Khadour, Yuling Fu, Wei-Ching Chang, et al.
European Heart Journal|April 26, 2003
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus studyLars Wallentin, Lott Bergstrand, Mikael Dellborg, et al.
American Heart Journal|April 9, 2011
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline riskRajendra H Mehta, Aijing Z Starr, Renato D Lopes, et al.
Journal of Interventional Cardiology|August 30, 2008
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussionMarc Cohen, James Hoekstra, Robert Giugliano, et al.
The Lancet. Neurology|March 21, 2014
Embolic strokes of undetermined source: the case for a new clinical constructRobert G Hart, Hans-Christoph Diener, Shelagh B Coutts, et al.
American Journal of Epidemiology|March 7, 2015
Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External ExpertsVéronique L Roger, Eric Boerwinkle, James D Crapo, et al.
Journal of the American Geriatrics Society|December 20, 2022
Lipid-lowering treatment among older patients with atherosclerotic cardiovascular diseaseMichael G Nanna, Adam J Nelson, Kevin Haynes, et al.
European Journal of Heart Failure|September 6, 2017
Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortalityElke Platz, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 91